Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
SUBDERMAL LEVONORGESTREL IMPLANTS - 3 YEARS EXPERIENCE IN CAIRO, EGYPT
Autore:
RIZK DEE;
Indirizzi:
VILLA 10,ST NO 5,4TH AREA,HELIOPOLIS CAIRO EGYPT LLANDOUGH HOSP,DEPT OBSTET & GYNAECOL CARDIFF S GLAM WALES AIN SHAMS UNIV,FAC MED CAIRO EGYPT
Titolo Testata:
Journal of reproductive medicine
fascicolo: 9, volume: 40, anno: 1995,
pagine: 638 - 644
SICI:
0024-7758(1995)40:9<638:SLI-3Y>2.0.ZU;2-Q
Fonte:
ISI
Lingua:
ENG
Soggetto:
LONG-TERM EXPERIENCE; NORPLANT IMPLANTS; 3-YEAR EXPERIENCE; CONTRACEPTION; WOMEN; FERTILITY; CAPSULES; RATES; RODS;
Keywords:
CONTRACEPTIVE DEVICES; FEMALE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
29
Recensione:
Indirizzi per estratti:
Citazione:
D.E.E. Rizk, "SUBDERMAL LEVONORGESTREL IMPLANTS - 3 YEARS EXPERIENCE IN CAIRO, EGYPT", Journal of reproductive medicine, 40(9), 1995, pp. 638-644

Abstract

OBJECTIVE: To assess the efficacy, safety and acceptability of the subdermal levonorgestrel implant (SLI), a new, long-acting, low-dose, progestin-only contraceptive method for women. STUDY DESIGN: A prospective, observational study conducted in the family planning clinic, Department of Obstetrics and Gynecology, Ain Shams University Hospital, Cairo, Egypt, as an advanced phase III clinical trial. RESULTS: This paper describes three years' experience with the SLI In 350 women. The netthree-year cumulative pregnancy rate was 0.98%. Menstrual disturbances, ranging from amenorrhea to menorrhagia, were the major side effectsand were present in 25% of women during the third year. These disturbances resulted in 28 removals, 19 of which were because of amenorrhea. Medical complications, including headache, hyhypertension and non-insulin dependent diabetes; desire for pregnancy; and complications at the insertion site (such as infection, spontaneous expulsion of the capsules and arm pain) were the principal reasons for another 57 implant removals. So far, no gynecologic or breast lesions have developed, and weight changes were not noted. The continuation rate after three yearstons 65.5%. CONCLUSION: The efficacy, safety and acceptability of theimplant suggest that it will provide an important addition to the contraceptive armamentarium.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/12/20 alle ore 19:49:03